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levels on elevated blood pressure among
middle-aged U.S. adults: a cross-sectional study
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Background: Scientists and regulators have sought to understand whether and how physiologic dysregulation due to
chronic stress exposure may enhance vulnerability to the adverse health effects of toxicant exposures. We conducted a
cross-sectional study to determine whether allostatic load (AL), a composite measure of physiologic response to
chronic exposure to stress, amplifies the effect of lead exposure on blood pressure among middle-aged adults.
Methods: We analyzed associations between blood lead levels and blood pressure in a nationally representative
sample of 8,194 U.S. adults (aged 40-65 years) participating in the National Health and Nutritional Examination Survey,
1999--2008. Outcomes were elevated systolic (≥ 140 mm Hg) and diastolic (≥ 90 mm Hg) blood pressure. AL was
defined as the aggregate score of seven components, reflecting dysregulation of the cardiovascular, inflammatory, and
endocrine systems.
Results: Logistic regression models showed a linear dose-response relationship for quintiles of blood lead and elevated
systolic blood pressure in the high AL group (p = 0.03) but not the low AL group (p = 0.24). Similarly, the relationship
between lead exposure and elevated diastolic blood pressure was stronger among the high AL group than the low AL
group. Within the high AL group, the fourth and fifth quintiles had significantly elevated odds of elevated blood
pressure compared to lowest quintile [OR = 1.92, (95% CI, 1.07, 3.47) and OR =2.28 (95% CI, 1.33, 3.91), respectively]. In
the low AL group, none of the quintile effects were significantly different than the referent group although there was
evidence of a linear trend (p =0.03). The lead by AL interaction term was not statistically significant for either systolic or
diastolic blood pressure models.
Conclusions: Results suggest that higher AL may amplify the adverse effects of lead on blood pressure. Future
research should assess the implications of cumulative exposures to environmental and social stressors for regulatory
decision-making.
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Regulatory agencies and environmental health scientists
are beginning to examine whether and how chronic stress
exposure potentially amplifies human vulnerability to the
adverse health effects of toxicant exposures [1]. Emerging
evidence suggests that cumulative physiological “wear and
tear” resulting from chronic over-activity of the body’s
stress-response system may impair immune functioning* Correspondence: rmf@berkeley.edu
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reproduction in any medium, provided the orand increase vulnerability to environmental stressors [2]
by increasing the absorption of toxicants into the body
through increased respiration, perspiration, and consump-
tion [3]; compromising the body’s defense systems against
toxicants; affecting the same physiological processes as en-
vironmental agents; and directly causing illness [4,5].
High blood pressure is a common condition among
U.S. adults and a major risk factor for strokes, heart
attacks, congestive heart failure, and kidney disease [6,7].
Minority and lower socio-economic status (SES) popula-
tions are at elevated risk of hypertension [6]. These pop-
ulations also encounter the double jeopardy of elevatedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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chronic social stressors [8,9]. While the root causes of
hypertension remain poorly understood, growing evi-
dence indicates that the interaction of environmental,
social, and genetic factors may partially explain the per-
sistent racial and socioeconomic disparities in cardiovas-
cular outcomes, such as hypertension [10-12].
Lead is a ubiquitous environmental contaminant that
can impair the cardiovascular system. Although lead was
removed from gasoline and household paint in the
1970s, the general population, and low SES populations
in particular, continue to be exposed to lead through oc-
cupational exposures, lead-based paint in older housing
stock, and the gradual release of lead from bone, which
serves as the body’s principal, long term repository for
this pollutant [13]. Cross-sectional and longitudinal epi-
demiologic studies demonstrate associations between
lead exposure and elevated blood pressure including de-
velopment of hypertension [14-17]. Animal studies have
confirmed this relationship and elucidated mechanisms
by which lead may influence blood pressure regulation
[18]. A systematic review by Navas-Acien et al. [19] con-
cluded that the evidence was sufficient to infer a causal
relationship between lead exposure and hypertension.
Chronic stress has also been associated with hyperten-
sion [20] and may interact with lead to stimulate the hypo-
thalamic–pituitary–adrenal (HPA) axis, promote oxidative
stress and inflammation, augment adrenergic activity, and
alter the renin-angiotensin system [18,21,22], which are
critical to blood pressure regulation. Chronic stress may re-
sult from myriad experiences such as job stress, racial dis-
crimination, and place-based stressors such as lack of basic
services, and exposure to violence [23-26]. Allostasis refers
to how the body’s stress-response systems regulate internal
physiology in response to chronic exposure to physical, so-
cial, and environmental stressors [27]. Allostatic load (AL)
refers to the cumulative biological burden exacted by on-
going dysregulation of the stress-response due to chronic
stress exposure [2,27,28]. AL encompasses physiologic
dysregulation of multiple systems affected by over-
activation of the HPA axis including, but not limited to,
the central nervous system, cardiovascular, immune, in-
flammatory, and endocrine systems [29]. Previous studies
have linked higher AL scores with increased risk of aging-
related health outcomes such as incident cardiovascular
disease, decline in physical functioning, decline in cognitive
function, and mortality [30-32]. Therefore, allostatic load is
a composite biomarker of the cumulative biological burden
exacted by ongoing disruption of the body’s stress-
response system [33] that may increase vulnerability to the
adverse health effects of toxicants, such as lead [8].
While potential synergistic effects between chronic
stress and lead exposures on blood pressure are
biologically plausible, only one epidemiologic study hasexamined these interactions. Peters et al. [34] reported a
significant interaction between bone lead exposures and
self-reported measures of stress on the development of
hypertension among a cohort of older, white men in the
Boston area. However, no previous study has examined
whether AL amplifies vulnerability to the adverse health ef-
fects of exposures to environmental toxicants, in particular,
lead. We hypothesized that middle-aged adults with higher
AL would be more vulnerable to the lead-induced effects
on blood pressure than adults with lower AL. To test this
hypothesis, we evaluated the association between blood
lead level and elevated systolic and diastolic blood pressure
in a cross-sectional study of middle-aged men and women
from the United States (U.S.). We then stratified our sample
between high versus low AL to examine differences in ef-
fect estimates between these two groups.
Methods
Study population
The National Health and Nutritional Examination Survey
(NHANES), conducted by the Centers for Disease Control
and Prevention (CDC), are a nationally representative sur-
vey and physical examination of the health and nutritional
status of the civilian, non-institutionalized U.S. population.
The survey also includes measurement of environmental
chemicals in blood and urine (Further information at
http://www.cdc.gov/nchs/nhanes.htm). NHANES obtained
informed consent from all study participants. Due to the
complex survey design, separate sample weights are
assigned to each survey participant; each participant repre-
sents approximately 50 000 other U.S. residents.
The present study combines participants from five
cycles of NHANES, spanning the years 1999 to 2008.
African Americans, Mexican Americans, and low-income
persons were oversampled in these survey cycles [35]. In this
study, we restricted the study population to the 9918 partici-
pants who were 40-65 years of age to minimize the effect of
confounding by age, which is strongly associated with lead
exposure, blood pressure, and AL [7,14,36]. Of these, we ex-
cluded participants who were missing measurements of
blood lead, blood pressure, components of AL, any model
covariates or who were currently pregnant (N= 1724), leav-
ing a total of 8194 eligible participants for our analyses.
Blood pressure outcomes
Three consecutive measurements of systolic and dia-
stolic blood pressures were taken during the NHANES
physical examination by certified examiners. We used
the mean of systolic and diastolic blood pressure mea-
surements in our analyses unless only one measurement
was available. Elevated systolic blood pressure was de-
fined as systolic blood pressure ≥ 140 mm Hg. Elevated
diastolic blood pressure was defined as diastolic blood
pressure ≥ 90 mm Hg. We did not evaluate clinical
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reported antihypertensive medication use as a separate
covariate in regression models. We chose this analytical
approach because people diagnosed with hypertension
who are taking medication may exhibit different health
behaviors from those who have undiagnosed and/or un-
treated elevated blood pressure which in turn, may affect
lead, allostatic load, and hypertension relationships. In
our study population, antihypertensive medication users
had significantly lower serum cotinine and alcohol con-
sumption levels than people with elevated blood pres-
sure who were not on medication (data not shown).
Blood lead measurements
Blood samples were obtained by venipuncture during the
physical examination, and lead concentrations were quan-
tified using inductively coupled plasma mass spectrometry
(CDC National Center for Environmental Health, Atlanta,
Georgia). Twelve participants (<1%) had blood lead con-
centrations below the limit of detection (LOD) (0.30 μg/






Informed by prior studies [37,38] as well as data availability
within NHANES, we operationalized AL by creating a cu-
mulative index of physiologic dysregulation of the cardio-
vascular, inflammatory, and endocrine systems using the
following seven biological markers: urinary creatinine,
serum albumin, urinary C-reactive proteins (biomarkers of
inflammation and immune response), plasma levels of
glycosolated hemoglobin, serum triglycerides, HDL serum
cholesterol (metabolic and cardiovascular biomarkers), and
waist circumference (anthropometric biomarker). Cut-
points were empirically defined using sex-specific quintiles
for each of the seven components. A value of one was
assigned to the lowest quintile and a value of five was
assigned to the highest quintile. The highest quintile always
corresponded to the highest risk category (e.g. large waist
circumference, low creatinine clearance). We calculated the
AL score by summing each participant’s rankings for the
seven components; the AL score ranged from seven to 35.
Statistical analyses
We calculated the mean and standard error (SE) for nor-
mally distributed variables such as systolic and diastolic
blood pressures, and geometric mean (GM) and geomet-
ric standard error (GSE) for lognormally distributed vari-
ables such as lead and cotinine. In bivariate analyses,
differences across groups were evaluated using the chi
square test for categorical data and analysis of variance
for continuous data.
We examined the association between lead exposure and
blood pressure in several ways. In our primary analysis, wemodeled systolic and diastolic blood pressure as dichoto-
mous variables using logistic regression. To allow for poten-
tial non-linear relationships, we categorized lead exposure
into quintiles and compared quintiles two, three, four,
and five to the lowest quintile. Quintile cutoffs were
based on the weighted distribution of lead. We also mo-
deled both the blood pressure and lead exposure as continu-
ous variables. In these models, blood lead concentrations
were natural log transformed prior to construction of multi-
variate models.
In addition to blood lead, the model included the follow-
ing biologic and social determinants of hypertension: age
(continuous), race/ethnicity (non-Hispanic white, non-
Hispanic black, Mexican American, other Hispanic, or
other race), educational attainment [less than 12th grade
(no diploma), high school graduate, some college/associ-
ates (AA) degree, or college graduate and above], and sex.
We adjusted all models for self-reported use of antihyper-
tensive medication (yes/no). The following potential con-
founders were also considered: marital status (married/
living with partner, divorced/separated/widowed, or never
married), smoking status (never, former, current), and al-
cohol consumption (never, < 1 drink per week, 1-3 drinks
per week, or > 3 drinks per week). These covariates were
retained in the final model if they were statistically signifi-
cant or if they changed the beta coefficient for lead expos-
ure by 10% or more.
To assess for potential effect modification by AL, we
stratified the final multivariate model of blood lead and el-
evated blood pressure by AL status divided at the median
AL score. To formally test the interactions observed in
our stratified models, we included a lead by allostatic load
interaction term in our full model along with cross-
product terms of AL with all covariates in the final model
(e.g. AL*sex, AL*age, etc.). To assess the impact of our
definition of “high AL”, we conducted a sensitivity analysis
where high AL was defined as an AL score above the 80th
percentile. Lastly, to evaluate the impact of antihyperten-
sive medication users on our results, we conducted a sen-
sitivity analysis by removing antihypertensive medication
users (n = 1640) from the final multivariate models.
All analyses were conducted in SUDAAN 10.0 (Re-
search Triangle Institute, Cary, NC) and SAS 9.2 (SAS
Institute Inc., Cary, NC). SUDAAN calculates variance
estimates after incorporating the non-random sampling
design and the sample population weights, which ac-
count for the unequal probability of selection into the
survey and the oversampling of certain subgroups. Since
we combined five cycles of data, we calculated new sam-
ple weights for each study participant according to the
NHANES analytical guidelines [39]. For participants sur-
veyed from 1999-2002, sample weights were equal to
two-fifths of the four year sample weights. For partici-
pants surveyed from 2003-2008, sample weights were
Table 1 Descriptive characteristics for adults aged 40 to 65 years (N = 8194) in the national health and nutritional














Blood lead (μg/dL); geometric mean (GSE) 1.69 (0.02) 0.76 (0.01) 1.25 (0.00) 1.67 (0.00) 2.25 (0.01) 3.88 (0.03) **
Systolic blood pressure (mm Hg); mean (SE) 124.33 (0.30) 122.23 (0.55) 122.43 (0.53) 124.59 (0.49) 125.48 (0.57) 126.92 (0.62) **
Diastolic blood pressure (mm Hg); mean (SE) 74.81 (0.20) 74.30 (0.37) 74.16 (0.38) 74.99 (0.32) 74.96 (0.32) 75.65 (0.34) **
Elevated blood pressure, % (SE)
Systolic > 140 mm Hg 16.4 (0.6) 13.9 (1.2) 13.3 (1.1) 15.9 (1.2) 17.5 (1.0) 21.4 (1.4) **
Diastolic > 90 mm Hg 7.8 (0.5) 5.5 (0.7) 6.5 (0.8) 8.1 (0.9) 9.2 (0.9) 9.6 (0.8) **
Age (years), mean (SE) 50.9 (0.15) 48.4 (0.22) 50.0 (0.25) 51.3 (0.27) 52.2 (0.26) 52.6 (0.21) **
Male sex, % (SE) 49.1 (0.6) 25.1 (1.7) 39.3 (1.5) 51.8 (1.4) 59.0 (1.5) 70.5 (1.5) **
Race/Ethnicity, % (SE) **
Non-Hispanic White 75.7 (1.3) 80.1 (1.6) 77.9 (1.7) 77.6 (1.4) 74.5 (1.6) 68.3 (2.1)
Non-Hispanic Black 9.7 (0.8) 6.7 (0.7) 8.3 (0.8) 8.8 (0.9) 9.9 (0.9) 14.8 (1.4)
Mexican American 5.7 (0.6) 5.3 (0.7) 5.2 (0.6) 5.5 (0.7) 5.4 (0.6) 7.2 (0.9)
Other Hispanic 4.2 (0.6) 4.0 (0.7) 4.6 (1.1) 4.4 (0.9) 4.1 (0.7) 4.1 (0.9)
Other 4.7 (0.4) 3.9 (0.7) 4.0 (0.7) 3.7 (0.6) 6.1 (0.9) 5.6 (0.8)
Educational attainment, % (SE) **
Less than 9th grade 5.4 (0.4) 3.2 (0.4) 4.2 (0.5) 5.7 (0.7) 5.6 (0.6) 8.3 (0.7)
9th - 12th grade (no diploma) 10.9 (0.5) 7.4 (0.9) 9.1 (0.8) 8.7 (0.9) 12.1 (0.9) 17.3 (1.2)
High school graduate or equivalent 24.6 (0.8) 22.7(1.5) 22.9 (1.5) 24.6 (1.4) 26.0 (1.5) 26.7 (1.4)
Some college or associates (AA) degree 30.6 (0.8) 32.0 (1.5) 30.3 (1.7) 32.1 (1.3) 29.5 (1.6) 29.3 (1.1)
College graduate or above 28.5 (1.2) 34.7 (2.0) 33.5 (2.0) 28.9 (1.9) 26.9 (1.7) 18.3 (1.4)
Marital status, % (SE) **
Married or living with partner 73.2 (0.8) 75.6 (1.6) 75.6 (1.2) 72.6 (1.4) 71.4 (1.5) 70.8 (1.4)
Divorced, separated, or widowed 19.9 (0.7) 17.5 (1.4) 18.3 (1.2) 20.0 (1.2) 22.2 (1.4) 21.6 (1.3)
Never married 6.9 (0.4) 6.9 (0.8) 6.1 (0.8) 7.4 (0.9) 6.4 (0.7) 7.7 (0.8)
Smoking status, % (SE) **
Never 47.2 (0.8) 69.1 (1.5) 56.4 (1.6) 45.4 (1.7) 36.3 (1.6) 28.9 (1.3)
Former 28.9 (0.7) 23.4 (1.3) 27.4 (1.5) 31.6 (1.4) 31.0 (1.3) 31.1 (1.4)
Current 23.9 (0.8) 7.4 (0.8) 16.2 (1.1) 23.0 (1.5) 32.7 (1.8) 40.0 (1.4)
Alcohol consumption, % (SE) **
None 25.5 (1.0) 36.9 (2.0) 30.0 (1.6) 22.1 (1.3) 21.8 (1.3) 16.6 (1.2)
Less than 1 drink per week 34.8 (0.9) 39.9 (1.7) 36.6 (1.5) 34.8 (1.6) 31.3 (1.4) 31.5 (1.6)
1 to 3 drinks per week 11.4 (0.5) 12.6 (1.1) 13.0 (1.1) 13.0 (1.0) 10.4 (0.9) 8.1 (0.7)
3 or more drinks per week 28.3 (0.9) 10.6 (1.2) 20.4 (1.3) 30.2 (1.7) 36.6 (1.5) 43.8 (1.7)
Use of antihypertensive medication, % (SE) 23.5 (0.7) 26.3 (1.5) 22.4 (1.5) 21.9 (1.3) 23.1 (1.3) 23.7 (1.4)
Abbreviations: GSE geometric standard error, SE standard error.
a All estimates are adjusted for survey design and sample weights. Differences across groups were evaluated using the chi square test for categorical data and
analysis of variance for continuous data. **P < 0. 05.
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tical tests for trends of categorical variables were
conducted by coding quintile categories as integers and
evaluating tests for significance on the slope of the re-
gression line. A (two-sided) P-value < 0.05 was consid-
ered significant and < 0.10 marginally significant.Results
Participant characteristics
We excluded participants who were missing data or were
pregnant (N = 1724), leaving a total of 8194 participants
for our analyses. There were no significant differences in
mean levels of blood lead concentration, blood pressure,
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tween the eligible and excluded groups. However, the
excluded group had a higher prevalence of systolic and
diastolic hypertension and a lower mean allostatic load
score. Those not included were also more likely to be
younger, female, non-Hispanic black or other/mixed
race, less educated, never married, current or former
smokers, and less likely to regularly drink alcohol (data
not shown).
In our final study sample, blood lead levels in the highest
lead quintile were approximately five times higher than
those in the lowest lead quintile (GM (GSE) = 3.88 (0.03)
μg/dL versus 0.76 (0.01) μg/dL). Participants in the higher
lead quintiles were more likely to be older, male, non-
Hispanic black, less educated, current smokers, and
regular drinkers (Table 1). Systolic and diastolic blood
pressures increased positively by blood lead quintile
(P < 0.01) while use of antihypertensive medication was
similar across lead quintiles (Table 1).
Distribution of blood lead quintiles varied by AL status,
and elevated blood pressures were more prevalent in the
high AL group (Table 2). Antihypertensive medication use
was approximately twice as common in the high AL group
compared to the low AL group. We observed a significant
inverse relationship between educational attainment andTable 2 Distribution of blood pressure measures, lead exposu
score among adults aged 40 to 65 years in the national healt
1999-2008 (N = 8194)
Variable Low allostatic
Blood pressure, % (SE)
Elevated systolic blood pressure 12.
Elevated diastolic blood pressure 6.9
Pb Exposure, % (SE)
Quintile 1 (≤1.05 μg/dL) 17.
Quintile 2 (1.06 - 1.44 μg/dL) 20.
Quintile 3 (1.45 – 1.90 μg/dL) 20.
Quintile 4 (1.91 – 2.69 μg/dL) 19.
Quintile 5 (> 2.70 μg/dL) 21.
Antihypertensive medication use, % (SE) 15.
Components of Allostatic Load
Triglycerides (mg/dL), 115.3 ± 1.5
HDL cholesterol (mg/dL) 59.8 ± 0
Waist circumference (cm) 91.8 ± 0.23
C-reactive protein (mg/dL) 0.23 ± 0.01
Creatinine (mg/dL) 123.66 ± 1
Albumin (g/dL) 4.38 ± 0.0
Glycosolated hemoglobin (%) 5.31 ± 0.0
Composite allostatic load score 16.9 ± 0
aLow allostatic load is equal to a score between 7 and 20. High allostatic load is eq
140 mm Hg and elevated diastolic BP defined as average BP ≥ 90 mm Hg.AL, and AL varied by race/ethnicity with non-Hispanic
Whites having the lowest AL score and Hispanics having
the highest AL score. Differences between Hispanics (both
Mexican American and other Hispanics) and non-
Hispanic Whites were statistically significant (P < 0.001)
while differences between non-Hispanic Whites and non-
Hispanic Blacks were not (data not shown).
Lead, allostatic load, and elevated blood pressure
In linear regression models for blood pressure modeled
continuously, lead exposure was a significant predictor
of elevated diastolic but not systolic blood pressure after
adjustment for covariates (Table 3). Diastolic blood pres-
sure was significantly higher in the fourth and fifth lead
exposure quintiles relative to the reference quintile, and
there was evidence of a linear, dose-response relation-
ship (P = 0.0001 for trend). When models were stratified
by high versus low AL, the association between lead and
systolic blood pressure was not significant in either of
the AL groups. For diastolic blood pressure, we observed
positive associations between lead exposure and diastolic
blood pressure in both AL groups. The highest lead
quintile had a larger effect on diastolic blood pressure
among the high AL group (ß =2.01; 95% CI, 0.24, 3.79)
than in the low AL group (ß = 1.79; 95% CI, 0.62, 2.95),re, and allostatic load components by allostatic load
h and nutritional examination survey, United States,
loada (N = 4069) High allostatic loada (N = 4125)
8 (0.8) 20.7 (0.8)
(0.5) 8.8 (0.6)
5 (1.0) 22.9 (1.0)
1 (0.9) 19.9 (0.8)
7 (0.9) 19.3 (0.8)
9 (0..7) 19.5 (0.9)
8 (0.8) 18.5 (0.8)
7 (0.7) 32.8 (0.9)
mean ± SE (range)
6 (26 - 1000) 222.3 ± 4.02 (31 - 3854)
.35 (8 -164) 44.9 ± 0.27 (12 - 108)
(59.4 -157.1) 108.35 ± 0.32 (70.7 – 168.4)
(0.01 - 17.5) 0.66 ± 0.02 (0.01 – 18.5)
.49 (7 – 609) 112.86 ± 1.61 (7 – 774)
1 (2.5 – 5.3) 4.16 ± 0.01 (2.3 - 5.3)
1 (3.3 – 14.0) 5.95 ± 0.02 (4.1 – 18.8)
.02 (7 – 21) 25.7 ± 0.06 (22-35)
ual to a score between 21 and 35. Elevated systolic BP defined as average BP ≥
Table 3 Adjusted difference in systolic and diastolic blood pressure by quintiles of blood lead exposure among adults
aged 40 to 65 years in the national health and nutritional examination survey, United States, 1999-2008a
All participants (N = 8,194) Low allostatic loadb (N = 4,069) High allostatic loadb (N = 4,125)
Difference 95% CI Difference 95% CI Difference 95% CI
Systolic blood pressure (mm Hg)c
Pb Exposure
Quintile 1 0 Reference 0 Reference 0 Reference
Quintile 2 −0.79 −2.07, 0.49 −1.08 −2.40, 0.25 0.13 −2.17, 2.44
Quintile 3 0.24 −1.22, 1.71 −0.27 −2.09, 1.55 1.68 −0.65, 4.02
Quintile 4 0.20 −1.26, 1.67 0.20 −1.59, 1.98 0.97 −1.50, 3.44
Quintile 5 0.63 −1.07, 2.33 0.67 −1.24, 2.58 1.60 −0.62, 3.82
Test for trend P = 0.24 P = 0.21 P = 0.14
Diastolic blood pressure (mm Hg)d
Pb Exposure
Quintile 1 0 Reference 0 Reference 0 Reference
Quintile 2 0.08 −0.80, 0.97 −0.30 −1.60, 1.01 0.80 −0.51, 2.11
Quintile 3 0.99 0.16, 1.82 1.06 0.03, 2.09 1.23 −0.11, 2.57
Quintile 4 1.17 0.25, 2.08 1.36 0.11, 2.60 1.21 −0.21, 2.63
Quintile 5 1.76 0.75, 2.78 1.79 0.62, 2.95 2.01 0.24, 3.79
Test for trend P = 0.0001 P = 0.0002 P = 0.02
Abbreviations: CI confidence interval.
aAdjusted for age, sex, race/ethnicity, education, marital status, smoking status, alcohol consumption, and antihypertensive medication use.
bLow allostatic load is equal to a score between 7 and 20. High allostatic load is equal to a score between 21 and 35.
cPb and AL test of interaction for systolic blood pressure: P = 0.75.
dPb and AL test of interaction for diastolic blood pressure: P = 0.77.
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tically significant (Table 3).
The effect of lead was more apparent when blood
pressure outcomes were modeled dichotomously using
clinical cutoffs for elevated blood pressure (Table 4).
There was evidence of a linear dose-response for quin-
tiles of blood lead and elevated systolic blood pressure
in the high AL group (p = 0.03) but not the low AL
group (p = 0.24). Similarly, the relationship between lead
exposure and elevated diastolic blood pressure was
stronger among the high AL group than the low AL
group. Within the high AL group, the fourth and fifth
quintiles had significantly increased odds of elevated
blood pressure compared to lowest quintile [OR = 1.92,
(95% CI, 1.07, 3.47) and OR =2.28 (95% CI, 1.33, 3.91),
respectively] and there was evidence of a linear, dose-
response relationships (p = 0.002). In the low AL group,
none of the quintile effects were significantly different
than the referent group although there was evidence of a
linear trend (p =0.03). The lead by AL interaction term
was not statistically significant for either systolic or dia-
stolic blood pressure models.
We also conducted several sensitivity analyses to exam-
ine the impact of model selection and AL definitions on
the results. A more extreme definition for high AL (i.e., the
top 80%), rendered larger differences in effect estimates forlead exposure between low and high AL groups (Figure 1).
However, these estimates also had wider confidence inter-
vals and the lead by AL interaction terms were not statisti-
cally significant. We also examined effects of lead exposure
modeled continuously. These results, which are presented
in Additional file 1: Tables S1 and Additional file 2: Table
S2, were generally similar to models in which lead expos-
ure was modeled in quintiles.
After removing antihypertensive medication users from
the analysis (Additional file 3: Tables S3 and Additional file
4: Table S4), effect estimates for lead exposure on differ-
ences in systolic blood pressure remained null in both
groups. However, in logistic regression models, lead effects
on odds of elevated systolic blood pressure in the highest
quintile were more pronounced in the high AL group (OR
= 1.75, (95% CI: 1.09, 2.83) compared to the low AL group
(OR = 1.08, (95% CI: 0.63, 1.84). Effect estimates for lead
exposure on differences in diastolic blood pressure in this
restricted model were similar to those obtained in the full
model. However, lead effects on the odds of elevated dia-
stolic blood pressure were attenuated in both groups, The
odds ratio for the fifth quintile relative to the reference
quintile was 1.33 (95% CI: 0.65, 2.73) and 1.82 (95% CI:
0.91, 3.64), in the low and high AL group, respectively, and
the linear dose response trends in either group were no
longer statistically significant.
Table 4 Adjusted odds ratio for elevated systolic and diastolic blood pressure by quintiles of blood lead exposure
among adults aged 40 to 65 years in the national health and nutritional examination survey, United States, 1999-2008a
All participants (N = 8,194) Low allostatic loadb (N = 4,069) High allostatic loadb (N = 4,125)
OR 95% CI OR 95% CI OR 95% CI
Elevated systolic blood pressure (≥ 140 mm Hg) c
Pb Exposure
Quintile 1 1.00 Reference 1.00 Reference 1.00 Reference
Quintile 2 0.87 0.66, 1.15 0.81 0.55, 1.19 0.96 0.66, 1.38
Quintile 3 1.00 0.76, 1.31 0.86 0.61, 1.21 1.20 0.82, 1.75
Quintile 4 1.03 0.78, 1.37 0.88 0.56, 1.39 1.23 0.86, 1.76
Quintile 5 1.23 0.92, 1.65 1.14 0.79, 1.66 1.40 0.99, 1.97
Test for trend P = 0.06 P = 0.24 P = 0.03
Elevated diastolic blood pressure (≥ 90 mm Hg) d
Pb Exposure
Quintile 1 1.00 Reference 1.00 Reference 1.00 Reference
Quintile 2 1.22 0.82, 1.81 0.85 0.45, 1.60 1.66 0.93, 2.95
Quintile 3 1.56 1.11, 2.19 1.51 0.83, 2.75 1.67 0.97, 2.85
Quintile 4 1.80 1.24, 2.60 1.73 0.96, 3.12 1.92 1.07, 3.47
Quintile 5 1.77 1.25, 2.50 1.46 0.80, 2.68 2.28 1.33, 3.91
Test for trend P = 0.0002 P = 0.03 P = 0.002
Abbreviations: CI confidence interval, OR odds ratio.
aAdjusted for age, sex, race/ethnicity, education, marital status, smoking status, alcohol consumption, and antihypertensive medication use.
bLow allostatic load is equal to a score between 7 and 20. High allostatic load is equal to a score between 21 and 35.
cPb and AL test of interaction for elevated systolic blood pressure: P = 0.74.
dPb and AL test of interaction for elevated diastolic blood pressure: P = 0.40.
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Interpretation of the results and underlying mechanisms
In this cross-sectional study of a nationally representative
population of U.S. middle-aged adults, we found slightly
higher effect estimates of low-level lead exposure on the
risk of elevated blood pressure among participants with
relatively higher AL. Higher blood lead levels were signifi-
cantly associated with increased odds of elevated systolic
and diastolic blood pressure among adults with high AL, a
biologic indicator of chronic stress response, while lead ef-
fects on blood pressure were less pronounced and not sig-
nificant for those in the low AL group. P-values for
multiplicative interactions between lead and AL were not
significant. Although this is the first examination of
whether higher AL may amplify vulnerability to the adverse
effects of lead exposure, our findings are consistent with
interactions between lead and psychosocial stressors ob-
served in animals [40], and in human studies [34,41,42].
Lead and chronic stress may impact several common bio-
logical pathways which could, in turn, affect blood pressure
regulation. Most importantly, both chronic stress and lead
can influence the HPA axis, which can promote inflamma-
tion, vasoconstriction, and adrenergic activity. Lead and
chronic stress can also increase the level of reactive oxygen
species leading to oxidative stress [18,22,43]. Stronger ef-
fects of lead exposure on blood pressure amongparticipants with higher AL may be a consequence of the
direct effect of lead on components of the physiological
stress response system underlying the AL measure. For ex-
ample, previous studies have found associations between
blood lead and general distress [44] and bone lead and
phobic anxiety [45]. However, in our study, the distribution
of lead exposure was similar between participants with
high versus low AL. Moreover, we observed significant
dose-response relationships between lead and blood pres-
sure among the high AL group, particularly for the dia-
stolic blood pressure outcome. The consistency of this
stronger effect across different lead levels and health out-
comes suggests that AL may in fact amplify the blood lead
and blood pressure relationship.
Comparison with other studies
Our study supports a growing body of epidemiological
evidence indicating that physiologic dysregulation due to
chronic stress may amplify observed associations be-
tween environmental pollutant exposures and adverse
health outcomes [4,5,8,23,46]. Peters et al. [34] examined
the modifying effects of self-reported stress on the rela-
tionship between bone lead and hypertension in a longi-
tudinal cohort of older white men from the greater
Boston area. They found that men with higher bone lead
concentrations and higher levels of stress are at
Figure 1 The association between quintile of blood lead exposure and odds of elevated systolic and diastolic blood pressure for those
with high allostatic load (high AL) versus those with low allostatic load (low AL) in the National Health and Nutritional Examination
Survey, United States, 1999-2008. All figures are adjusted for age, age squared, sex, race/ethnicity, educational attainment, marital status,
cotinine, alcohol consumption, and anti-hypertensive medication. In Figures A and B, high AL is defined as the top 50th percentile whereas in
Figures C and D, high AL is defined as the top 20th percentile.
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with lower stress levels. In cross-sectional analyses of
subjects without hypertension at baseline, they found an
interactive effect between lead and stress for systolic bloodpressure but not diastolic blood pressure. In this study, we
observed stronger lead effects by AL on diastolic blood
pressure for various model specifications. Among the high
AL group in the main analyses (Table 4), effect estimates
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sure than systolic blood pressure. When participants tak-
ing hypertensive medications were removed in the
sensitivity analysis (Additional file 3: Table S3 and Add-
itional file 4: Table S4), stronger effects were still observed
among the higher AL group for diastolic blood pressure
in the linear regression models, but these effects were
non-significant in the logistic models (Additional file 4:
Table S4).
Results of most previous studies report small but sig-
nificant effects of lead exposure on both systolic and dia-
stolic blood pressure [15,16]. Some studies report
stronger effects on diastolic blood pressure whereas in
other studies the reverse is true [16]. These inconsisten-
cies may result from differences in ranges of lead expo-
sures, age of study participants, measurement error
associated with blood pressure determination, and co-
variates included in the analysis. For example, systolic
blood pressure increases linearly with age, whereas dia-
stolic blood pressure increases with age up to 55 and
then declines [7]. Therefore, elevated diastolic blood
pressure may be more common among our study popu-
lation of middle-aged adults than studies with older pop-
ulations. Indeed, our results showing lead exposure
effects on diastolic blood pressure across all participants
(Tables 3 and 4) are consistent with those from another
study that examined effects of blood lead levels on ele-
vated blood pressure among women aged 40-59 years
from the NHANES III survey [47].
Strengths and limitations
We had a large, heterogeneous study population which en-
hanced our ability to detect effects of lead exposure on
blood pressure among participants with relatively higher
AL. The racial and economic diversity provided by the
NHANES sampling strategy is particularly useful for this
analysis since lead exposures and AL scores were both so-
cioeconomically patterned. Moreover, we were able to con-
trol for a number of potential confounders including: age,
educational attainment, race/ethnicity, smoking, alcohol
consumption, marital status, and antihypertensive medica-
tion use. However, residual confounding remains possible.
In addition, the cross-sectional design of our study pre-
cludes a systemic assessment of the temporality of lead ex-
posure and allostatic load, the potential for reverse
causation between hypertension and AL, or the potential
effects of cumulative lead exposures throughout the life
course, since blood lead (as opposed to bone lead) mostly
reflects recent and ongoing exposures as well as lead that
has been mobilized from tissue stores such as bone [48].
Nevertheless, although our study could not address these
limitations, we did systematically evaluate the robustness
of our findings with different model specifications, and our
results generally persisted in sensitivity analyses.Most human health studies analyzing whether chronic
stress exposure amplifies associations between pollutant
exposures and adverse health outcomes have relied on
self-assessments of chronic stress exposure, or individual
and area-level SES metrics as proxies for stress exposure
[23,34,41,49,50]. This is the first study to assess whether
physiologic dysregulation as measured by allostatic load,
amplifies vulnerability to the adverse health effects of toxi-
cant exposures. Importantly, we used the NHANES data
set that did not include the primary mediators of HPA axis
activity (e.g. cortisol, epinephrine, norepinephrine, dehy-
droepiandrosterone sulfate (DHEA-S)), and instead uti-
lized biomarkers of secondary effects of the chronic stress
response. Findings from previous studies using similar AL
algorithms with NHANES data suggest that the AL metric
is useful in describing the biological risks associated with
being socially disadvantaged. For example, AL scores are
higher among socially marginalized groups [51,52] and AL
attenuates the social gradients in ischaemic heart disease
and periodontal disease [38]. Although alternate ap-
proaches to measuring AL using different metrics or ap-
plying different additive and weighting approaches have
been considered [29], research indicates that no one
approach has consistently stronger predictive value for dif-
ferent health outcomes [26,36,53], particularly cardiovas-
cular effects. Instead, AL is a cumulative index that
characterizes the combined effects of small, subclinical
changes in several physiological systems [54]. The advan-
tage of the AL score is that it provides an integrated, bio-
logical measure of physiologic dysregulation due to
chronic stress response, although it does not elucidate the
dominant sources of chronic stress in the study popula-
tion. Despite the methodological challenges of under-
standing the extent to which AL is a direct indicator of
stress exposure, future research should utilize biological
measures of stress response in conjunction with subjective
assessments of stress exposure and objective metrics of in-
dividual and area-level SES that may act as proxy indica-
tors of social stressors (e.g. neighborhood-level poverty
rate and individual perception of community social stand-
ing) [10,55]. This approach could enhance understanding
about the modifying potential of different chronic
stressors on pollutant exposures and adverse health out-
come relationships.
Conclusions
Our finding that AL may amplify the effect of blood lead
on blood pressure suggests the need for more research
to better understand the relevant biological and psycho-
social pathways through which chemical exposures may
differently affect the health of vulnerable populations, a sig-
nificant portion of whom are disproportionately exposed
to chronic psychosocial stressors (e.g. material deprivation,
exposure to violence, lack of nutrition or access to health
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biological pathways, improve assessment of temporal
issues, and facilitate further examination of interactive
effects of environmental and social stress on other intrin-
sically susceptible populations (e.g. children) for other
adverse health outcomes such as cognitive development,
which has been linked to both chronic stress and lead
exposure [40]. Most important, these results suggest that
the “double jeopardy” of environmental and social stressors
needs to be more systematically integrated into regulatory
science and decision-making in order to better protect the
health of vulnerable populations who often face dispropor-
tionate and elevated exposures to multiple chemical and
non-chemical hazards.
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